Frías-Sánchez Z, Pantoja-Garrido M, Gómiz-Rodríguez G, Pantoja-Rosso FJ

Language: Spanish
References: 17
Page: 390-395
PDF size: 303.15 Kb.

ABSTRACT

Postpartum cardiomyopathy is a potentially life-threatening condition and can be associated with significant maternal and fetal morbidity and mortality. Most patients present within the first 4 months after delivery or in the last month of gestation. Many signs and symptoms of cardiac failure are often mistaken for pregnancy or peripartum. We use electrocardiogram, chest radiograph, and significantly elevated auricular natriuretic peptide levels to diagnose it although echocardiographic evaluation is essential to confirm a global left ventricular systolic dys- function. Treatment is consistent with management of dilated cardiomyopathy with the exception to avoid use of teratogenic. Nevertheless, pregnancies subsequent in women who have suffered from the above mentioned pathology are related to relapses, so it should discourage it or, if finally there is pregnancy, is necessary to advise precaution and a specialized units treatment.

REFERENCES

1. Plasencia W, Castro N, Barber M, Valls JM, et al. Miocardiopatía periparto como causa de insuficiencia cardiaca durante la gestación. Prog Obstet Ginecol 2004; 47(5): 241-84.

2. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation 1990;81:922.

3. Cenac A, Beaufils H, Soumana I, Vetter JM, Devillechabrolle A, Maulias R. Absence of humoral autoimmunity in peripartum cardiomyopathy. A comparative study in Niger. Int J Cardiol 1990;26:49.

4. Homans DC. Peripartum cardiomyopathy. N Eng J Med1985;312:1432.

5. Garg J, Palaniswamy C, Lanier GM. Peripartum cardiomyopathy: definition, incidence, etiopathogenesis, diagnosis, and management. Cardiology in review 2015;23(2):69-78.

6. Laverde-Sabogal CE, Garnica-Rosas LM, Correa-Gon´zalez N. Informe de caso sobre cardiomiopatía periparto: rara, desconocida y potencialmente fatal. Rev Colomb Anestesiol 2015;44(1)63-68.

7. Lee W. Clinical management of gravid women with peripartum cardiomyopathy. Obstet Gynecol Clin North Am 1991;18:257.

8. Pijuan Domènecha A, Gatzoulis MA. Embarazo y Cardiopatía. Rev Esp Cardiol 2006;59 (9):971-84.

9. Hall ME, George EM, Granger JP. El corazón durante el embarazo. Rev Esp Cardiol 2011;64(11):1045-1050.

10. Ortega Bravo M, Barco-Lopez MA, Calvo-Godoy MC, Vola. Jove N. Cuadro de insuficiencia cardiaca en mujer joven: miocardiopatía posparto. Semergen 2011;37(7):372-374.

11. Bollen IA, Van Deel ED, Kuster DW, Van Der Velden JP. Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart. Front Physiol 2015;15(5):531.

12. Mouquet F, Bouabdallaoui N. Peripartum cardiomyopathy. Presse Med 2015;44(7-8):798-804.

13. Domenech-Asensi P, Hernández-Palazón J, Tortosa-Serrano JA, Burguillos-López S, Alonso-Miranda B. Miocardiopatía periparto y edema pulmonar tras cesárea .Rev. Esp Anestesiol Reanim 2002;49:156-159.

14. McGregor AJ, Barron R, Rosene-Montella K. The pregnant heart: cardiac emergencies during pregnancy. Am J Emerg Med 2015;33(4):573-579.

15. Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol 2011;58(2011):659- 670.

16. Acosta-Ussa KL. Uso de bromocriptina en miocardiopatía periparto: revisión de la literatura. Universidad del Rosario, Bogotá. 2013. [en línea]. Dirección URL: .

17. Hilfiker-Kleiner D, Bauersachs J. Cardiovascular disease in pregnancy. Dtsch Med Wochenschr 2016;141(2):110-4.